CrushSCI.com
104.4平均天数
89.5中位天数
46最短天数
245最长天数
2912025发文量

Paper Review Records

全部论文审稿周期

30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

153 天

A prospective controlled study assessing postpartum breastfeeding in women with type 2 diabetes: lower rates associated with elevated BMI rather than diabetes

作者
Fiona L. Britten; Emma L. Duncan; Leonie K. Callaway展开收起
作者单位
1. Department of Obstetric Medicine, Women’s and Newborn Services, Royal Brisbane and Women’s Hospital, Brisbane, Australia; 2. Department of Endocrinology, Royal Brisbane and Women’s Hospital, Brisbane, Australia; 3. Medical School, University of Queensland, Brisbane, Australia; 4. Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK; 5. Department of Endocrinology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK展开收起
PDF源文件 DOI 网页
144 天

CCKBR signalling controls human definitive endoderm specification and pancreatic lineage differentiation

作者
Lama Saber; Kei Kozawa; Christos Karampelias; Changying Jing; Jessica Jaki; Melis Akgün Canan; Michael Sterr; Osvaldo Rodrigues Pereira; Oliver Czarnecki; Gregory S. Korbutt; Andrew R. Pepper; Noel Moya; Ingo Burtscher; Heiko Lickert; Mostafa Bakhti展开收起
作者单位
1. Institute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany; 2. German Center for Diabetes Research (DZD), Neuherberg, Germany; 3. School of Medicine, Technical University of Munich (TUM), Munich, Germany; 4. Munich Medical Research School (MMRS), Ludwig Maximilian University (LMU), Munich, Germany; 5. Stem Cell Institute, Ankara University, Ankara, Türkiye; 6. Alberta Diabetes Institute, Li Ka Shing Centre for Research, Edmonton, Canada; 7. Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada; 8. Regenerative Medicine Division, Delphi Stem, Inc., Atlanta, USA展开收起
PDF源文件 DOI 网页
54 天

Prediabetes subtype-based stratification reveals distinct long-term risks for type 2 diabetes

作者
Hun Jee Choe; Wonsuk Choi; Howard H. Chang; Dimple Kondal; K. M. Venkat Narayan; Joon Ho Moon; Nam H. Cho展开收起
作者单位
1. Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea; 2. Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea; 3. Department of Biological Chemistry, University of California Irvine, Irvine, USA; 4. Emory Global Diabetes Research Center, Woodruff Health Sciences Center and Emory University, Atlanta, USA; 5. Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, USA; 6. Public Health Foundation of India, New Delhi, India; 7. Centre for Chronic Disease Control, New Delhi, India; 8. Department of Epidemiology, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, USA; 9. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea; 10. Department of Preventive Medicine, Ajou University School of Medicine, Suwon, Korea展开收起
PDF源文件 DOI 网页
54 天

Renal tubule-specific Nrf2 deletion ameliorates diabetic kidney disease by attenuating glomerular hypertension and kidney injury in a mouse model of diabetes

作者
Ke Su; Jing Zhou; Yuchao Pang; Shiao-Ying Chang; Min-Chun Liao; Wen-Xia Yang; Shuiling Zhao; Junzheng Peng; Daniel N. Leal; Michifumi Yamashita; Kana N. Miyata; Janos G. Filep; Julie R. Ingelfinger; Shao-Ling Zhang; John S. D. Chan展开收起
作者单位
1. Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) and Département de Médecine, Université de Montréal, Montréal, Canada; 2. Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, USA; 3. Division of Nephrology, Department of Internal Medicine, Saint Louis University, St Louis, USA; 4. Centre de Recherche, Hôpital Maisonneuve-Rosemont and Département de Pathologie et Biologie Cellulaire, Université de Montréal, Montréal, Canada; 5. Pediatric Nephrology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, USA展开收起
PDF源文件 DOI 网页
144 天

A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes

作者
Sun H. Kim; Ipsa Arora; Charles Agyemang; Ranjit M. Anjana; Bjørn Olav Åsvold; Marieke Blom; Shilpa N. Bhupathiraju; Amélie Bonnefond; Juliana C. N. Chan; Timothy M. E. Davis; Kristian Hveem; Marit E. Jørgensen; Anton Lager; Lars Lind; Olle Melander; Andrea Natali; Jackie Price; Parminder Raina; Michael Roden; Olov Rolandsson; Mary R. Rooney; Seyed Mohammad Mousavi; Andrei C. Sposito; Reimar W. Thomsen; Barbara Thorand; Rob M. Van Dam; Kavita Venkataraman; Sarah H. Wild; Ji Hee Yu; Petra J. M. Elders; Joline W. Beulens; Femke Rutters展开收起
作者单位
1. Division of Endocrinology, Gerontology and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, USA; 2. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Central Maine Medical Center, Lewiston, USA; 3. Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands; 4. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, USA; 5. Department of Diabetology, Madras Diabetes Research Foundation & Dr. Mohan’s Diabetes Specialities Centre, ICMR Centre for Advanced Research on Diabetes, Chennai, India; 6. HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; 7. Department of Endocrinology, Clinic of Medicine, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway; 8. Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands; 9. Channing Division of Network Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston, USA; 10. University of Lille, Inserm/CNRS UMR 1283/8199, Institut Pasteur de Lille, European Genomics Institute for Diabetes (EGID), Lille University Hospital, Lille, France; 11. Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Science, Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, The Prince of Wales Hospital, Hong Kong SAR, China; 12. Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Australia; 13. Department of Research, St Olav’s Hospital, Trondheim, Norway; 14. Steno Diabetes Center Greenland, Nuuk, Greenland; 15. Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden; 16. Department of Medical Sciences, Uppsala University, Uppsala, Sweden; 17. Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; 18. Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden; 19. Meta Lab, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 20. Usher Institute, School of Population Health Sciences, University of Edinburgh, Edinburgh, UK; 21. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada; 22. McMaster Institute for Research on Aging, McMaster University, Hamilton, Canada; 23. Labarge Centre for Mobility in Aging, McMaster University, Hamilton, Canada; 24. Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich Heine University, Düsseldorf, Germany; 25. German Center for Diabetes Research (DZD e.V.), Partner München-Neuherberg, Neuherberg, Germany; 26. Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany; 27. Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; 28. Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA; 29. Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, USA; 30. Division of Cardiology, Department of Medicine, State University of Campinas, Campinas, Brazil; 31. Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark; 32. Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany; 33. Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Pettenkofer School of Public Health, Munich, Germany; 34. Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, The George Washington University, Washington, USA; 35. Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, USA; 36. Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Republic of Singapore; 37. Usher Institute for Population Health Sciences, University of Edinburgh, Edinburgh, UK; 38. Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea; 39. Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam University Medical Center, Amsterdam, the Netherlands展开收起
PDF源文件 DOI 网页
47 天

A multi-centre study of belatacept and sirolimus for islet transplantation

作者
Natasha M. Rogers; Min Hu; Elvira Jimenez-Vera; Hugh Gabor; Preeti P. Sharma; Colleen Etherton; Tom Loudovaris; Wayne J. Hawthorne; Chris J. Drogemuller; David J. Torpy; Deborah J. Holmes-Walker; Brian Gloss; Shane T. Grey; David Goodman; P. Toby Coates; Tom W. Kay; Philip J. O’Connell展开收起
作者单位
1. National Pancreas Transplant Unit, Westmead Hospital, Westmead, Australia; 2. Centre for Transplant and Renal Research, Westmead Institute for Medical Research, Westmead, Australia; 3. Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia; 4. Renal and Transplantation Medicine, Westmead Hospital, Westmead, Australia; 5. Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia; 6. Immunology and Diabetes Unit, St Vincent’s Institute of Medical Research, Melbourne, Australia; 7. Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia; 8. Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, Australia; 9. Westmead Bioinformatics Facility, Westmead Institute for Medical Research, Westmead, Australia; 10. School of Biotechnology and Biomolecular Sciences, Faculty of Science, The University of New South Wales, Sydney, Australia; 11. Department of Nephrology, St Vincent’s Hospital Melbourne, Fitzroy, Australia; 12. Department of Medicine, The University of Melbourne, Parkville, Australia展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。